Hong Kong Healthtech Stock News

Bank of Qingdao (SEHK:3866) has put shareholder returns and capital structure in focus after its 2025 AGM, approving a cash dividend and confirming the full early redemption of its RMB 2b tier two capital bonds. See our latest analysis for Bank of Qingdao. Recent price action has been mixed, with a 1-day share price return of 0.69% at HK$4.35 following the AGM, set against a 30-day share price decline of 9.38%. However, the year to date share price return of 13.87% and a 3-year total...

Governance changes and recent financial recovery take center stage Kingdee International Software Group (SEHK:268) has drawn fresh attention after shareholders approved new amended and restated Articles of Association, together with the company’s recent shift from a net loss to net income in 2025. See our latest analysis for Kingdee International Software Group. Despite the recent governance changes and return to profitability, the share price has been under pressure, with the 1-year total...

Those following along with FWD Group Holdings Limited ( HKG:1828 ) will no doubt be intrigued by the recent purchase of...

Potential CStone Pharmaceuticals ( HKG:2616 ) shareholders may wish to note that the CEO, President of R&D and...

Investors who take an interest in China Wantian Holdings Limited ( HKG:1854 ) should definitely note that the Executive...

Over the past year, insiders sold CN¥5.6m worth of Fujing Holdings Co., Limited ( HKG:2497 ) stock at an average price...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Tongguan Gold...

Insiders who acquired HK$2.48m worth of Anchorstone Holdings Limited's ( HKG:1592 ) stock at an average price of...

Kowloon Development Company Limited ( HKG:34 ) stock is about to trade ex-dividend in 3 days. The ex-dividend date...

Recent share price move puts Shenzhen Creality 3D Technology in focus A sharp one day move has put Shenzhen Creality 3D Technology (SEHK:3388) on investors’ radar, with the stock falling about 9% in the latest session and roughly 8% year to date. With a market value of about HK$9.8b and reported revenue of CN¥3,127.04m against a net loss of CN¥182.561m, the company sits at an interesting point for investors assessing growth potential versus current profitability. See our latest analysis for...

It looks like Fountain Set (Holdings) Limited ( HKG:420 ) is about to go ex-dividend in the next 3 days. The...

Recent share performance and company snapshot WuXi Biologics (Cayman) (SEHK:2269) has seen mixed share performance recently, with the stock edging up about 1% over the past day but declining around 10% over the past 3 months. The company runs an end to end biologics contract research, development, and manufacturing business, serving clients across North America, Europe, the People’s Republic of China, and other regions. It reported revenue of CN¥21,790.018 million and net income of...

At the 2026 ASCO Annual Meeting, Sichuan Kelun-Biotech Biopharmaceutical reported past Phase III and Phase II data in NSCLC, including sacituzumab tirumotecan plus pembrolizumab showing longer progression-free survival than pembrolizumab alone and lunbotinib fumarate delivering high response rates in RET fusion-positive disease, alongside encouraging first-in-human results for its B7-H3 ADC SKB500. The inclusion of sacituzumab tirumotecan data in The Lancet and the acceptance of lunbotinib’s...

Everest Medicines Stock Moves After Recent Performance Metrics Everest Medicines (SEHK:1952) has drawn fresh attention as investors review recent share performance and financial metrics, with the stock down 1% over the past day and 4.6% over the past week. See our latest analysis for Everest Medicines. That 1 day and 7 day share price weakness comes on top of a 30 day share price return of down 14.8% and a year to date decline of 24.1%. The 3 year total shareholder return of about 1.7x the...

BYD (SEHK:1211) has said it will assume liability for its advanced driver-assistance system, signaling a higher level of accountability for its technology. The company has also outlined plans to introduce solid-state batteries by 2027, targeting the next generation of electric vehicle battery performance. BYD shares last closed at HK$89.7, with the stock down 32.5% over the past year and still positive over 3 and 5 years, up 10.5% and 29.5% respectively. Against that backdrop, the company...

Insiders who acquired CN¥7.35m worth of Beauty Farm Medical and Health Industry Inc.'s ( HKG:2373 ) stock at an average...

Those following along with Softcare Limited ( HKG:2698 ) will no doubt be intrigued by the recent purchase of shares by...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

We feel now is a pretty good time to analyse Ocumension Therapeutics' ( HKG:1477 ) business as it appears the company...

JiaXing Gas Group Co., Ltd. ( HKG:9908 ) stock is about to trade ex-dividend in four days. Typically, the ex-dividend...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Those following along with Geely Automobile Holdings Limited ( HKG:175 ) will no doubt be intrigued by the recent...

Vobile Group Limited ( HKG:3738 ), is not the largest company out there, but it received a lot of attention from a...

It looks like Nissin Foods Company Limited ( HKG:1475 ) is about to go ex-dividend in the next three days. Typically...